In April of this year LARA voted to change Gabapentin to a schedule V substance. MAPS and LARA have both indicated those rules haven’t been made public/enforceable yet. We are aware of the email sent by a drug company, but right now this ruleset it still awaiting action by JCAR (Joint Committee of Administrative Rules) and has not yet been completed.
Read the Full News Release Here
From MVMA's lobbyist: Rules have to go before JCAR for at least 15 legislative session days. Generally speaking, JCAR does not act within the 15 days and the rules go back to ORR (Office of Regulatory Reinvention) for a certificate of adoption before then being filed with the Secretary of State. The rules were presented to JCAR on August 31st. With that said, 15 session days will not likely occur until Mid-December. So in all likelihood, we are looking at mid to late December until the rule goes into effect.
Please let us know if you have any questions. MVMA will update our members as we learn more.